Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live webcast. [Operator instructions] With that, I would like to hand over to Ms. Sloan Simpson, head of investor relations. Please go ahead, madam. Sloan Simpson--Head of Investor Relat...
Novartis Investor RelationsCentral investor relations line: +41 61 324 7944E-mail: investor.relations@novartis.com Central North America Samir Shah +41 61 324 7944 Sloan Simpson +1 862 345 4440 Nicole Zinsli-Somm +41 61 324 3809 Alina ...
Novartis Media Relations E-mail:media.relations@novartis.com North America Julie Masow +1 862 579 8456 Michael Meo +1 862 274 5414 Marlena Abdinoor +1 617 335 9525 Novartis Investor Relations E-mail:investor.relations@novartis.com North America ...
mary.curtin_creaser@novartis.com Novartis Investor Relations E-mail:investor.relations@novartis.com North America Sloan Simpson +1 862 778 5052 View original content:http://www.prnewswire.com/news-releases/novartis-inves...
Central investor relations line: +41 61 324 7944E-mail: investor.relations@novartis.com Central North America Isabella Zinck +41 61 324 7188 Sloan Simpson +1 862 345 4440 Nicole Zinsli-Somm +41 61 324 3809 Jonathan Graham +1 20...
ESG targets We aim to improve equity in healthcare and to create sustainable social and environmental impact. Living wage We are committed to paying employees wages that cover basic living needs. Patient organization funding We work with groups that advocate for patients and disclose these relationshi...
Novartis Media Relations E-mail:media.relations@novartis.com North America Julie Masow +1 862 579 8456 Michael Meo +1 862 274 5414 Marlena Abdinoor +1 617 335 9525 Novartis Investor Relations E-mail:investor...
Microsoft Media Relations WE Communications for Microsoft (425) 638-7777 rrt@we-worldwide.com http://news.microsoft.com Eric Althoff Novartis US External Communications +1 646 438 4335 eric.althoff@novartis.com Novartis Investor Relations Central investor relations line: +41 61...
anja.von_treskow@novartis.com Kara Cournoyer Novartis Institutes for BioMedical Research Communications +617 710 5447 (mobile) kara.cournoyer@novartis.com Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail:investor.relations@novartis.com...
Head of Investor Relations jordan.silverstein@adacap.com Tel: + 1-212-235-2394 Photos accompanying this announcement are available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c0e0ed62-0e8e-4202-a78a-a65d05ad37a7 http://www.globenewswire.com/NewsRoom/AttachmentNg/...